DE69413606T2 - Endothelinantagonistische Peptide - Google Patents

Endothelinantagonistische Peptide

Info

Publication number
DE69413606T2
DE69413606T2 DE69413606T DE69413606T DE69413606T2 DE 69413606 T2 DE69413606 T2 DE 69413606T2 DE 69413606 T DE69413606 T DE 69413606T DE 69413606 T DE69413606 T DE 69413606T DE 69413606 T2 DE69413606 T2 DE 69413606T2
Authority
DE
Germany
Prior art keywords
antagonistic peptides
endothelin antagonistic
endothelin
peptides
antagonistic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69413606T
Other languages
English (en)
Other versions
DE69413606D1 (de
Inventor
Kiyofumi Ishikawa
Takehiro Fukami
Masaki Ihara
Mitsuo Yano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD KK
Original Assignee
Banyu Phamaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Phamaceutical Co Ltd filed Critical Banyu Phamaceutical Co Ltd
Publication of DE69413606D1 publication Critical patent/DE69413606D1/de
Application granted granted Critical
Publication of DE69413606T2 publication Critical patent/DE69413606T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57536—Endothelin, vasoactive intestinal contractor [VIC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE69413606T 1993-06-03 1994-06-01 Endothelinantagonistische Peptide Expired - Fee Related DE69413606T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15790793 1993-06-03

Publications (2)

Publication Number Publication Date
DE69413606D1 DE69413606D1 (de) 1998-11-05
DE69413606T2 true DE69413606T2 (de) 1999-04-15

Family

ID=15660055

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69413606T Expired - Fee Related DE69413606T2 (de) 1993-06-03 1994-06-01 Endothelinantagonistische Peptide

Country Status (5)

Country Link
US (1) US5494897A (de)
EP (1) EP0632052B1 (de)
AU (1) AU673731B2 (de)
CA (1) CA2124989A1 (de)
DE (1) DE69413606T2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5430022A (en) * 1990-05-14 1995-07-04 Fujisawa Pharmaceutical Co., Ltd. Peptide compound and its preparation
US5614497A (en) * 1991-12-27 1997-03-25 Takeda Chemical Industries, Ltd. Peptide, production and use thereof
PT1165613E (pt) 1999-03-29 2008-07-29 Procter & Gamble Ligantes do receptor de melanocortina
FR2913978B1 (fr) * 2007-03-21 2009-07-03 Centre Nat Rech Scient Procede de synthese de peptides sans solvant
KR102236829B1 (ko) 2013-03-15 2021-04-07 프로타고니스트 테라퓨틱스, 인코포레이티드 헵시딘 유사체 및 이의 용도
PT3143037T (pt) 2014-05-16 2021-09-24 Protagonist Therapeutics Inc Antagonistas peptídicos tioéter de integrina alfa4beta7
US9624268B2 (en) 2014-07-17 2017-04-18 Protagonist Therapeutics, Inc. Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
MX2017004300A (es) 2014-10-01 2017-12-18 Protagonist Therapeutics Inc ANTAGONISTAS DE MONOMÉRICOS Y DIMÉRICOS PEPTÍDICOS DE A4ß7 NOVEDOSOS.
US10787490B2 (en) 2015-07-15 2020-09-29 Protaganist Therapeutics, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
WO2017117411A1 (en) 2015-12-30 2017-07-06 Protagonist Therapeutics, Inc. Analogues of hepcidin mimetics with improved in vivo half lives
CA3089868A1 (en) 2018-02-08 2019-08-15 Protagonist Therapeutics, Inc. Conjugated hepcidin mimetics
US20200040037A1 (en) * 2018-07-12 2020-02-06 Protagonist Therapeutics, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
EP3997105A4 (de) 2019-07-10 2023-09-13 Protagonist Therapeutics, Inc. Peptidinhibitoren des interleukin-23-rezeptors und deren verwendung zur behandlung entzündlicher erkrankungen
CN118027153A (zh) 2020-01-15 2024-05-14 詹森生物科技公司 介白素-23受体的肽抑制剂及其治疗炎性疾病的用途
MX2023005994A (es) 2020-11-20 2023-08-11 Janssen Pharmaceutica Nv Composiciones de inhibidores peptidicos del receptor de interleucina-23.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2032559C (en) * 1989-12-28 2001-11-06 Kiyofumi Ishikawa Endothelin antagonistic cyclic pentapeptides
CA2043741C (en) * 1990-06-07 2003-04-01 Kiyofumi Ishikawa Endothelin antagonistic peptide derivatives
US5144918A (en) * 1990-07-19 1992-09-08 Mazda Motor Corporation Intake system for engine
GB9300048D0 (en) * 1993-01-04 1993-03-03 Wellcome Found Endothelin converting enzyme inhibitors

Also Published As

Publication number Publication date
EP0632052B1 (de) 1998-09-30
AU673731B2 (en) 1996-11-21
EP0632052A1 (de) 1995-01-04
US5494897A (en) 1996-02-27
CA2124989A1 (en) 1994-12-04
DE69413606D1 (de) 1998-11-05
AU6345494A (en) 1994-12-22

Similar Documents

Publication Publication Date Title
DE4393381T1 (de) Peptide
DE69129395D1 (de) Antimikrobielle Peptide
DK6893D0 (da) Peptid
DE69332485T2 (de) Immunmodulierende peptide
NO942066L (no) Peptidderivater
NO943190D0 (no) Sulfonamid-endothelin-antagonister
IS4115A (is) Ný peptíð
DE69413606D1 (de) Endothelinantagonistische Peptide
DE69433229D1 (de) ATM-Schalter
FI940109A0 (fi) Peptidejä
DE69931010D1 (de) Peptide mit osteogener Aktivität
DE69427363D1 (de) Plättchenaggregationsinhibierende peptide
FI944428A (fi) Viruksen vastaisia peptidejä
DE69232771D1 (de) Peptide als antagonisten von endothelin
BR9606756A (pt) Peptídeo
NO981052D0 (no) Peptidderivater
NO981051D0 (no) Peptidderivater
NO932237D0 (no) Lineaere peptider
ATE471944T1 (de) Antineoplastische peptide
KR960702848A (ko) 옥시토신 길항적 활성을 나타내는 펩티드
DE69420044T2 (de) Blutregulierende peptide
DE68914057T2 (de) Peptide.
NO962204D0 (no) Dobbeltkjedede hemoregulatoriske peptider
DK104493D0 (da) Hidtil ukendte peptider
SE9504467D0 (sv) Peptide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee